{"component": "clause", "props": {"groups": [{"snippet": "Seller agrees to buy, from time to time, Buyer's on-hand inventory that is in excess of Buyer's own production requirements and is needed for Seller's production. Seller also agrees to make inventory in excess of Seller's production requirements available for sale to the Buyer, to any of Buyer's Affiliates or Authorized Agents or anyone else designated by Buyer. Seller's obligation to sell such inventory to any Buyer's Authorized Agent or to anyone else designated by Buyer, is subject to Seller's determining such entities' credit worthiness is acceptable to Seller. Transfer quantities and payment terms will be mutually agreed on a case-by-case basis. Prices shall be [*]. -------------------------------------------------------------------------------- Iomega WS, Supplier RM Rev. P, July 30, 1997 -- -- Page 4 of 26 --------------------------------------------------------------------------------", "snippet_links": [{"key": "agrees-to", "type": "clause", "offset": [7, 16]}, {"key": "from-time-to-time", "type": "clause", "offset": [22, 39]}, {"key": "of-buyer", "type": "clause", "offset": [85, 93]}, {"key": "production-requirements", "type": "clause", "offset": [100, 123]}, {"key": "for-seller", "type": "definition", "offset": [138, 148]}, {"key": "of-seller", "type": "clause", "offset": [210, 219]}, {"key": "sale-to-the-buyer", "type": "clause", "offset": [260, 277]}, {"key": "authorized-agents", "type": "definition", "offset": [311, 328]}, {"key": "by-buyer", "type": "clause", "offset": [355, 363]}, {"key": "obligation-to-sell", "type": "clause", "offset": [374, 392]}, {"key": "subject-to-seller", "type": "definition", "offset": [482, 499]}, {"key": "credit-worthiness", "type": "definition", "offset": [529, 546]}, {"key": "and-payment-terms", "type": "clause", "offset": [592, 609]}, {"key": "mutually-agreed", "type": "definition", "offset": [618, 633]}, {"key": "page-4", "type": "clause", "offset": [812, 818]}], "samples": [{"hash": "jgqGskiOn9g", "uri": "/contracts/jgqGskiOn9g#inventory-transfer", "label": "Supply Agreement (Manufacturers Services LTD)", "score": 18.0, "published": true}, {"hash": "ilxXITkUTsI", "uri": "/contracts/ilxXITkUTsI#inventory-transfer", "label": "Supply Agreement (Manufacturers Services LTD)", "score": 18.0, "published": true}, {"hash": "c7gVKpUDarO", "uri": "/contracts/c7gVKpUDarO#inventory-transfer", "label": "Supply Agreement (Manufacturers Services LTD)", "score": 18.0, "published": true}], "size": 3, "hash": "45f22ac0aa92c0851691f96528d2174b", "id": 1}, {"snippet": "Upon the termination of this Agreement, Abbott shall transfer all remaining firm orders of Products pursuant to Section 2.1(b), work in process and raw materials relating to the Products manufactured pursuant to this Agreement to Hospira at Hospira\u2019s expense, unless such termination shall have been as a result of a breach of this Agreement by Abbott or the early termination of this Agreement pursuant to Section 4.1, in which case such inventory, work in process and raw materials shall be returned at \u2587\u2587\u2587\u2587\u2587\u2587\u2019\u2587 expense.", "snippet_links": [{"key": "upon-the-termination", "type": "clause", "offset": [0, 20]}, {"key": "firm-orders", "type": "definition", "offset": [76, 87]}, {"key": "pursuant-to-section", "type": "clause", "offset": [100, 119]}, {"key": "work-in-process", "type": "clause", "offset": [128, 143]}, {"key": "raw-materials", "type": "definition", "offset": [148, 161]}, {"key": "relating-to", "type": "definition", "offset": [162, 173]}, {"key": "the-products", "type": "clause", "offset": [174, 186]}, {"key": "agreement-to", "type": "definition", "offset": [217, 229]}, {"key": "termination-shall", "type": "clause", "offset": [272, 289]}, {"key": "breach-of-this-agreement", "type": "definition", "offset": [317, 341]}, {"key": "early-termination-of-this-agreement", "type": "clause", "offset": [359, 394]}, {"key": "section-41", "type": "clause", "offset": [407, 418]}], "samples": [{"hash": "jS7hxXiAEWW", "uri": "/contracts/jS7hxXiAEWW#inventory-transfer", "label": "Api Supply Agreement", "score": 31.3408622742, "published": true}, {"hash": "6GcnjDDorpS", "uri": "/contracts/6GcnjDDorpS#inventory-transfer", "label": "Api Supply Agreement (Hospira Inc)", "score": 21.0, "published": true}], "size": 3, "hash": "c59364373fbaaf4abb6dca0fb85829eb", "id": 3}, {"snippet": "At the written request of Celgene, Prothena shall promptly assign and transfer to Celgene (or its designee) and deliver to Celgene (or its designee) (at a location to be specified by Celgene to Prothena), any or all (as and to the extent requested by Celgene) inventory of Licensed Antibodies and Licensed Products held by or on behalf of Prothena or its Affiliates as of the Effective Date (including any such inventory held at any contract manufacturer or any other location); provided that Celgene shall pay to Prothena a reasonable, fair value cost for such transferred inventory, which cost shall be negotiated in good faith and agreed to by the Parties prior to such transfer (the \u201cLicensed Program Inventory\u201d).", "snippet_links": [{"key": "written-request", "type": "definition", "offset": [7, 22]}, {"key": "transfer-to", "type": "definition", "offset": [70, 81]}, {"key": "deliver-to", "type": "definition", "offset": [112, 122]}, {"key": "by-celgene", "type": "clause", "offset": [180, 190]}, {"key": "to-the-extent", "type": "clause", "offset": [224, 237]}, {"key": "requested-by", "type": "definition", "offset": [238, 250]}, {"key": "licensed-antibodies", "type": "definition", "offset": [273, 292]}, {"key": "licensed-products", "type": "definition", "offset": [297, 314]}, {"key": "by-or-on-behalf-of", "type": "definition", "offset": [320, 338]}, {"key": "as-of-the-effective-date", "type": "clause", "offset": [366, 390]}, {"key": "contract-manufacturer", "type": "definition", "offset": [433, 454]}, {"key": "provided-that", "type": "definition", "offset": [479, 492]}, {"key": "pay-to", "type": "definition", "offset": [507, 513]}, {"key": "fair-value", "type": "clause", "offset": [537, 547]}, {"key": "transferred-inventory", "type": "definition", "offset": [562, 583]}, {"key": "in-good-faith", "type": "clause", "offset": [616, 629]}, {"key": "by-the-parties", "type": "clause", "offset": [644, 658]}, {"key": "prior-to", "type": "clause", "offset": [659, 667]}, {"key": "program-inventory", "type": "definition", "offset": [697, 714]}], "samples": [{"hash": "1PRlwCf6H1w", "uri": "/contracts/1PRlwCf6H1w#inventory-transfer", "label": "Master Collaboration Agreement", "score": 31.3408622742, "published": true}, {"hash": "jyCPZUGoLnP", "uri": "/contracts/jyCPZUGoLnP#inventory-transfer", "label": "Master Collaboration Agreement (Prothena Corp PLC)", "score": 29.6242294312, "published": true}, {"hash": "8T8ysQBgaFY", "uri": "/contracts/8T8ysQBgaFY#inventory-transfer", "label": "Master Collaboration Agreement (Prothena Corp PLC)", "score": 29.3504447937, "published": true}], "size": 3, "hash": "473c7c80066fd1ed890e87abf466c22a", "id": 2}, {"snippet": "On Ziopharm\u2019s reasonable request following the Effective Date, Precigen shall transfer to Ziopharm or its designee some or all of its inventory of IL-12 Products (including all final product, drug substance, intermediates, works-in-process, formulation materials, reference standards, drug product clinical reserve samples, packaged retention samples, and the like) that is then in the possession or Control of Precigen or its Affiliates or sublicensees and in quantities reasonably requested by Ziopharm; provided that Ziopharm shall pay Precigen a price equal to Precigen\u2019s historical cost plus [*****] percent ([*****]%) for any such transferred IL-12 Product.", "snippet_links": [{"key": "reasonable-request", "type": "definition", "offset": [14, 32]}, {"key": "following-the-effective-date", "type": "clause", "offset": [33, 61]}, {"key": "transfer-to", "type": "definition", "offset": [78, 89]}, {"key": "il-12-products", "type": "definition", "offset": [147, 161]}, {"key": "final-product", "type": "clause", "offset": [177, 190]}, {"key": "drug-substance", "type": "clause", "offset": [192, 206]}, {"key": "reference-standards", "type": "definition", "offset": [264, 283]}, {"key": "drug-product", "type": "clause", "offset": [285, 297]}, {"key": "reserve-samples", "type": "clause", "offset": [307, 322]}, {"key": "retention-samples", "type": "definition", "offset": [333, 350]}, {"key": "control-of", "type": "definition", "offset": [400, 410]}, {"key": "requested-by", "type": "definition", "offset": [483, 495]}, {"key": "provided-that", "type": "definition", "offset": [506, 519]}, {"key": "equal-to", "type": "definition", "offset": [556, 564]}, {"key": "cost-plus", "type": "definition", "offset": [587, 596]}], "samples": [{"hash": "k0vP1upzTCJ", "uri": "/contracts/k0vP1upzTCJ#inventory-transfer", "label": "Exclusive License Agreement", "score": 30.3408622742, "published": true}, {"hash": "4Kfq92A4c0R", "uri": "/contracts/4Kfq92A4c0R#inventory-transfer", "label": "Exclusive License Agreement (Intrexon Corp)", "score": 29.8514709473, "published": true}], "size": 3, "hash": "a0c4725aa38e467f9b6e83cd58003519", "id": 4}, {"snippet": "In connection with the grant of the Reversion License, within [***] of expiration of the Wind-down Period, Licensee shall notify Licensor of any quantity of the Licensed Product remaining in Licensee\u2019s inventory and to the extent requested by Licensor\u2019s request, Licensee will transfer to Licensor any inventory of Licensed Products in the possession or control of Licensee or its Affiliates as of the termination date at a price equal to [***].", "snippet_links": [{"key": "in-connection-with", "type": "clause", "offset": [0, 18]}, {"key": "grant-of", "type": "clause", "offset": [23, 31]}, {"key": "reversion-license", "type": "definition", "offset": [36, 53]}, {"key": "expiration-of-the", "type": "clause", "offset": [71, 88]}, {"key": "licensee-shall", "type": "clause", "offset": [107, 121]}, {"key": "quantity-of", "type": "clause", "offset": [145, 156]}, {"key": "to-the-extent", "type": "clause", "offset": [216, 229]}, {"key": "by-licensor", "type": "clause", "offset": [240, 251]}, {"key": "licensee-will", "type": "clause", "offset": [263, 276]}, {"key": "transfer-to-licensor", "type": "clause", "offset": [277, 297]}, {"key": "licensed-products", "type": "definition", "offset": [315, 332]}, {"key": "of-licensee", "type": "clause", "offset": [362, 373]}, {"key": "termination-date", "type": "definition", "offset": [402, 418]}, {"key": "equal-to", "type": "definition", "offset": [430, 438]}], "samples": [{"hash": "3QzRjB9WkWL", "uri": "/contracts/3QzRjB9WkWL#inventory-transfer", "label": "License and Collaboration Agreement (Cullinan Oncology, LLC)", "score": 29.96235466, "published": true}, {"hash": "gHZsORYsrO", "uri": "/contracts/gHZsORYsrO#inventory-transfer", "label": "License and Collaboration Agreement (Cullinan Oncology, LLC)", "score": 29.8364143372, "published": true}], "size": 2, "hash": "a27d6ce62f83e8916f59f319123bc2b7", "id": 5}, {"snippet": "a. Plexus will purchase Active Inventory from Harmonic and its subcontractors at Plexus standard cost, subject to such inventory meeting Plexus and Harmonic\u2019s reasonable inspection and acceptance criteria, less Plexus\u2019 MOH charges.\nb. Active Inventory is defined as usable and within Harmonic forecasted demand in next 12 months plus identified end-of-life raw material (up to [*]). The value of this Active Inventory is estimated to be [*] to [*]. Inventory transfers from Harmonic subcontractors will be sold directly to Plexus. In the event any conflict arises between Plexus and Harmonic\u2019s subcontractors, then, Harmonic agrees to take an active role in resolving the issues.", "snippet_links": [{"key": "standard-cost", "type": "clause", "offset": [88, 101]}, {"key": "subject-to", "type": "clause", "offset": [103, 113]}, {"key": "inspection-and-acceptance-criteria", "type": "clause", "offset": [170, 204]}, {"key": "raw-material", "type": "clause", "offset": [357, 369]}, {"key": "the-value", "type": "clause", "offset": [383, 392]}, {"key": "transfers-from", "type": "definition", "offset": [459, 473]}, {"key": "subcontractors-will", "type": "clause", "offset": [483, 502]}, {"key": "in-the-event", "type": "clause", "offset": [531, 543]}, {"key": "agrees-to", "type": "clause", "offset": [625, 634]}, {"key": "the-issues", "type": "clause", "offset": [668, 678]}], "samples": [{"hash": "hw6nIDRt4hP", "uri": "/contracts/hw6nIDRt4hP#inventory-transfer", "label": "Professional Services Agreement", "score": 31.3408622742, "published": true}, {"hash": "g76skYbOD4H", "uri": "/contracts/g76skYbOD4H#inventory-transfer", "label": "Professional Services Agreement (Harmonic Inc)", "score": 21.0, "published": true}], "size": 2, "hash": "c0b933f449d8b833d82605884c8b5f74", "id": 6}, {"snippet": "Promptly following the Effective Date and receipt of all upfront payments by BII, BII shall conduct an inventory transfer to CENTREXION with respect to the Development Compounds, such transferred inventory to include drug substance as further specified in the Tech Transfer Agreement. BII shall provide the transfer of the inventory described in the Tech Transfer Agreement subject to CENTREXION\u2019s satisfaction of its reimbursement or payment obligations as set forth in the Tech Transfer Agreement. STRICTLY CONFIDENTIAL AND ATTORNEY-CLIENT-PRIVILEGED DRAFT - BII - CENTREXION - PATENT ASSIGNMENT AND LICENSING AGREEMENT", "snippet_links": [{"key": "following-the-effective-date", "type": "clause", "offset": [9, 37]}, {"key": "receipt-of", "type": "clause", "offset": [42, 52]}, {"key": "payments-by", "type": "clause", "offset": [65, 76]}, {"key": "transfer-to", "type": "definition", "offset": [113, 124]}, {"key": "with-respect-to", "type": "clause", "offset": [136, 151]}, {"key": "development-compounds", "type": "clause", "offset": [156, 177]}, {"key": "transferred-inventory", "type": "definition", "offset": [184, 205]}, {"key": "drug-substance", "type": "clause", "offset": [217, 231]}, {"key": "tech-transfer-agreement", "type": "definition", "offset": [260, 283]}, {"key": "the-inventory", "type": "clause", "offset": [319, 332]}, {"key": "subject-to", "type": "clause", "offset": [374, 384]}, {"key": "satisfaction-of", "type": "clause", "offset": [398, 413]}, {"key": "payment-obligations", "type": "definition", "offset": [435, 454]}, {"key": "strictly-confidential", "type": "definition", "offset": [500, 521]}, {"key": "licensing-agreement", "type": "clause", "offset": [602, 621]}], "samples": [{"hash": "7kwqP5ZGdqe", "uri": "/contracts/7kwqP5ZGdqe#inventory-transfer", "label": "Patent Assignment and Licensing Agreement (Centrexion Therapeutics Corp)", "score": 29.8432579041, "published": true}, {"hash": "evSQQDg8oaa", "uri": "/contracts/evSQQDg8oaa#inventory-transfer", "label": "Patent Assignment and Licensing Agreement (Centrexion Therapeutics Corp)", "score": 29.7967147827, "published": true}], "size": 2, "hash": "180db0131be98d52fe6058c403d7e40e", "id": 7}, {"snippet": "As soon as reasonably practicable following the Effective Date (but in all cases within thirty (30) days after Chimerix\u2019s receipt of the upfront payment pursuant to Section 5.1), Chimerix shall transfer and deliver to Merck (at a location to be specified by Merck to Chimerix), at no additional cost, all inventory of Compound and Product (including inventory of cGMP and non-cGMP bulk Compound as well as bulk Product) held by or on behalf of Chimerix or any of its Affiliates (including any such inventory held at any contract manufacturer) (the \u201cInventory\u201d). The quantity of such Inventory shall be at a minimum, the quantities as set forth on Schedule 3.2, which schedule shall be broken down by cGMP and non-cGMP bulk Compound as well as by cGMP and non-cGMP bulk Product.", "snippet_links": [{"key": "following-the-effective-date", "type": "clause", "offset": [34, 62]}, {"key": "in-all-cases", "type": "clause", "offset": [68, 80]}, {"key": "within-thirty", "type": "clause", "offset": [81, 94]}, {"key": "days-after", "type": "definition", "offset": [100, 110]}, {"key": "receipt-of", "type": "clause", "offset": [122, 132]}, {"key": "upfront-payment", "type": "definition", "offset": [137, 152]}, {"key": "section-51", "type": "clause", "offset": [165, 176]}, {"key": "deliver-to", "type": "definition", "offset": [207, 217]}, {"key": "by-merck", "type": "clause", "offset": [255, 263]}, {"key": "no-additional-cost", "type": "clause", "offset": [281, 299]}, {"key": "all-inventory", "type": "clause", "offset": [301, 314]}, {"key": "bulk-compound", "type": "definition", "offset": [381, 394]}, {"key": "bulk-product", "type": "definition", "offset": [406, 418]}, {"key": "by-or-on-behalf-of", "type": "definition", "offset": [425, 443]}, {"key": "contract-manufacturer", "type": "definition", "offset": [520, 541]}, {"key": "quantity-of", "type": "clause", "offset": [566, 577]}, {"key": "the-quantities", "type": "clause", "offset": [616, 630]}, {"key": "on-schedule", "type": "definition", "offset": [644, 655]}], "samples": [{"hash": "bc1VhcNzrnQ", "uri": "/contracts/bc1VhcNzrnQ#inventory-transfer", "label": "Collaboration and Exclusive License Agreement (Chimerix Inc)", "score": 24.1813831329, "published": true}, {"hash": "93I4du146m8", "uri": "/contracts/93I4du146m8#inventory-transfer", "label": "Collaboration and Exclusive License Agreement (Chimerix Inc)", "score": 24.0800819397, "published": true}], "size": 2, "hash": "8624efc5746ef9dc9eaa6007a61179e5", "id": 8}, {"snippet": "At the request of Merck from time to time as set forth in the Transition Plan, NewLink shall promptly transfer title to Merck and deliver to Merck (or its designee) (at a location to be [*]), [*] any or all (as and to the extent [*]) inventory of Compound and Product (including [*]) held by or on behalf of NewLink or any of its Affiliates (including any such inventory [*]) (the \u201cInventory\u201d).", "snippet_links": [{"key": "the-request", "type": "clause", "offset": [3, 14]}, {"key": "from-time-to-time", "type": "clause", "offset": [24, 41]}, {"key": "transition-plan", "type": "definition", "offset": [62, 77]}, {"key": "title-to", "type": "clause", "offset": [111, 119]}, {"key": "deliver-to", "type": "definition", "offset": [130, 140]}, {"key": "to-the-extent", "type": "clause", "offset": [215, 228]}, {"key": "by-or-on-behalf-of", "type": "definition", "offset": [289, 307]}], "samples": [{"hash": "7PI8YwZMowI", "uri": "/contracts/7PI8YwZMowI#inventory-transfer", "label": "License and Collaboration Agreement (Newlink Genetics Corp)", "score": 26.201915741, "published": true}], "size": 2, "hash": "af24e514430805261108e7c6c7044278", "id": 9}, {"snippet": "(i) GVI hereby agrees to transfer all of its right, title and interest in and to the inventory identified on Schedule 1 hereto (the \u201cInventory\u201d) to SSC as provided below. GVI shall make the Inventory available to SSC for inspection (the \u201cInspection\u201d) by a representative of SSC during normal business hours at its warehouse located at \u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587, \u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587 \u2587\u2587\u2587\u2587\u2587 (the \u201cGVI Warehouse\u201d) until the close of business on September 13, 2006. Upon its completion of the Inspection, SSC shall promptly, and in no event later than the close of business on September 14, 2006, notify GVI in writing of any material inconsistency between Schedule I hereto and the Inventory located at the GVI Warehouse (any such inconsistency shall consist solely of missing or visibly damaged items, a \u201cDeficiency\u201d), which shall be the sole purpose of the Inspection. In the event that SSC provides GVI with any such written notice of Deficiency, SSC shall have no obligation to cause the Inventory to be shipped at GVI\u2019s expense to the SSC Warehouse (as defined below) until such Deficiency has been cured by GVI. In the event SSC has not caused the Inspection to be conducted by the close of business on September 13, 2006, SSC shall be deemed to have waived its rights of inspection hereunder, and GVI shall thereafter, at GVI\u2019s own expense, be entitled to ship the Inventory to a \u201cTop Gun\u201d warehouse designated by SSC located in the State of California (the \u201cSSC Warehouse\u201d). In the event that SSC conducts the Inspection and does not provide GVI with any notice of Deficiency as set forth in this Section 1(i), SSC shall cause the Inventory to be shipped to the SSC Warehouse at GVI\u2019s expense by a carrier selected by SSC, which shall be reasonably acceptable to GVI, no later than the close of business on September 15, 2006; in the event that SSC fails to cause the Inventory to be removed from the GVI Warehouse by such time, GVI shall thereafter, at GVI\u2019s own expense, be entitled to ship the Inventory to the SSC Warehouse. SSC shall take title to the Inventory (and risk of loss shall pass to SSC) only upon the removal of the Inventory from the GVI Warehouse for delivery to the SSC Warehouse by SSC\u2019s carrier or GVI\u2019s carrier, as applicable.\n(ii) SUBJECT TO THE PRECEDING PARAGRAPH, THE ESI PARTIES REPRESENT THAT THEY HAVE HAD THE OPPORTUNITY TO INSPECT AND ARE FULLY FAMILIAR WITH THE INVENTORY AND HEREBY COVENANT AND AGREE THAT THEY ACCEPT THE CONDITION OF THE INVENTORY \u201cAS IS\u201d AND \u201cWHERE IS\u201d. EXCEPT AS SET FORTH IN THIS AGREEMENT, GVI HAS NOT MADE, AND IS NOT WILLING TO MAKE, ANY REPRESENTATIONS OR WARRANTIES AS TO THE PHYSICAL CONDITION OR WORKING ORDER OF THE INVENTORY OR THE INCOME POTENTIALLY TO BE DERIVED FROM THE SALE OF THE INVENTORY. GVI EXPRESSLY DISCLAIMS ANY AND ALL EXPRESS OR IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE WITH RESPECT TO THE INVENTORY. NEITHER GVI NOR ANY OF ITS SUBSIDIARIES ARE, NOR WILL ANY OF THEM BE, LIABLE OR BOUND IN ANY MANNER BY EXPRESS OR IMPLIED WARRANTIES, GUARANTEES, STATEMENTS, PROMISES, REPRESENTATIONS OR INFORMATION PERTAINING TO THE INVENTORY, MADE OR FURNISHED BY ANY AGENT, EMPLOYEE OR OTHER PERSON REPRESENTING OR PURPORTING TO REPRESENT GVI, UNLESS SUCH ARE EXPRESSLY AND SPECIFICALLY SET FORTH HEREIN.", "snippet_links": [{"key": "to-transfer", "type": "clause", "offset": [22, 33]}, {"key": "title-and-interest", "type": "clause", "offset": [52, 70]}, {"key": "schedule-1", "type": "definition", "offset": [109, 119]}, {"key": "available-to", "type": "definition", "offset": [200, 212]}, {"key": "for-inspection", "type": "clause", "offset": [217, 231]}, {"key": "normal-business-hours", "type": "definition", "offset": [285, 306]}, {"key": "close-of-business", "type": "clause", "offset": [408, 425]}, {"key": "the-inspection", "type": "clause", "offset": [472, 486]}, {"key": "in-no-event", "type": "clause", "offset": [512, 523]}, {"key": "in-writing", "type": "clause", "offset": [591, 601]}, {"key": "schedule-i", "type": "definition", "offset": [640, 650]}, {"key": "damaged-items", "type": "clause", "offset": [772, 785]}, {"key": "purpose-of-the", "type": "clause", "offset": [828, 842]}, {"key": "in-the-event", "type": "clause", "offset": [855, 867]}, {"key": "notice-of-deficiency", "type": "clause", "offset": [912, 932]}, {"key": "no-obligation-to", "type": "clause", "offset": [949, 965]}, {"key": "rights-of-inspection", "type": "clause", "offset": [1252, 1272]}, {"key": "the-state-of-california", "type": "clause", "offset": [1420, 1443]}, {"key": "any-notice", "type": "clause", "offset": [1543, 1553]}, {"key": "title-to-the", "type": "clause", "offset": [2036, 2048]}, {"key": "risk-of-loss", "type": "clause", "offset": [2064, 2076]}, {"key": "removal-of", "type": "clause", "offset": [2110, 2120]}, {"key": "delivery-to-the", "type": "clause", "offset": [2162, 2177]}, {"key": "subject-to-the", "type": "clause", "offset": [2247, 2261]}, {"key": "opportunity-to-inspect", "type": "clause", "offset": [2332, 2354]}, {"key": "condition-of-the", "type": "clause", "offset": [2448, 2464]}, {"key": "in-this-agreement", "type": "definition", "offset": [2519, 2536]}, {"key": "representations-or-warranties", "type": "clause", "offset": [2588, 2617]}, {"key": "physical-condition", "type": "definition", "offset": [2628, 2646]}, {"key": "order-of", "type": "clause", "offset": [2658, 2666]}, {"key": "sale-of-the", "type": "clause", "offset": [2730, 2741]}, {"key": "warranties-of-merchantability-and-fitness-for-a-particular-purpose", "type": "clause", "offset": [2808, 2874]}, {"key": "with-respect-to-the-inventory", "type": "clause", "offset": [2875, 2904]}, {"key": "pertaining-to", "type": "definition", "offset": [3105, 3118]}, {"key": "other-person", "type": "definition", "offset": [3178, 3190]}], "samples": [{"hash": "4ZsHbsHJRq5", "uri": "/contracts/4ZsHbsHJRq5#inventory-transfer", "label": "Inventory Transfer Agreement (Gvi Security Solutions Inc)", "score": 19.0, "published": true}], "size": 1, "hash": "b8c3cab7995ac67db1a8424f18dc9584", "id": 10}], "next_curs": "ClsSVWoVc35sYXdpbnNpZGVyY29udHJhY3RzcjcLEhZDbGF1c2VTbmlwcGV0R3JvdXBfdjU2IhtpbnZlbnRvcnktdHJhbnNmZXIjMDAwMDAwMGEMogECZW4YACAA", "clause": {"size": 45, "parents": [["term-and-termination", "Term and Termination"], ["assistance-technology-transfer", "Assistance; Technology Transfer"], ["inventory-transfer-and-manufacturing-technology-transfer", "Inventory Transfer and Manufacturing Technology Transfer"], ["definitions", "DEFINITIONS"], ["effects-of-expiration-or-termination", "Effects of Expiration or Termination"]], "children": [["transition", "Transition"], ["", ""], ["excusing-performance", "Excusing Performance"], ["disclaimer", "Disclaimer"], ["notice", "Notice"]], "title": "Inventory Transfer", "id": "inventory-transfer", "related": [["current-inventory-of-qualified-property", "CURRENT INVENTORY OF QUALIFIED PROPERTY", "CURRENT INVENTORY OF QUALIFIED PROPERTY"], ["sale-of-inventory", "Sale of Inventory", "Sale of Inventory"], ["inventory-management", "Inventory Management", "Inventory Management"], ["qualified-property", "Qualified Property", "Qualified Property"], ["inventory", "Inventory", "Inventory"]], "related_snippets": [], "updated": "2026-04-02T05:40:27+00:00", "also_ask": ["What are the essential representations and warranties needed in an Inventory Transfer clause?", "How can the clause allocate risk for defective or obsolete inventory?", "What negotiation levers exist regarding timing and valuation of transferred inventory?", "How does this clause compare to standard UCC Article 2 provisions on goods transfer?", "What documentation or delivery requirements are critical for enforceability in court?"], "drafting_tip": "Specify the items to be transferred to prevent disputes; set clear transfer timing to ensure operational continuity; require written acknowledgment to confirm receipt and condition.", "explanation": "The Inventory Transfer clause governs the process by which ownership or possession of inventory is transferred from one party to another, typically in the context of a sale, merger, or business transition. It outlines the specific terms under which inventory items are identified, valued, and delivered, and may address issues such as timing, condition of goods, and responsibility for costs or risks during the transfer. This clause ensures that both parties have a clear understanding of their rights and obligations regarding inventory, thereby minimizing disputes and facilitating a smooth transition of assets."}, "json": true, "cursor": ""}}